Graft-versus-host disease (GVHD)-specific survival and duration of systemic immunosuppressive treatment in patients who developed chronic GVHD following allogeneic haematopoietic cell transplantation

British Journal of Haematology

Volumn 122, Issue 4, 2003, Pages 637-644

  Lee, Jung Hee ^a   Lee, Je Hwan ^a,b   Choi, Seong Jun ^a   Kim, Shin ^a   Seol, Miee ^a   Lee, Young Shin ^a   Lee, Jung Shin ^a   Kim, Woo Kun ^a   Lee, Kyoo Hyung ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Chronic GVHD; Immunosuppressive treatment; Survival

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; BUSULFAN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PENTAMIDINE; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DEATH; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYCOSIS; MYELODYSPLASTIC SYNDROME; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; SURVIVAL RATE; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0043163747     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04472.x     Document Type: Article

References (36)

1. Akpek, G., Zahurak, M.L., Piantadosi, S., Margolis, J., Doherty, J., Davidson, R. & Vogelsang, G.B. (2001) Development of a prognostic model for grading chronic graft-versus-host disease. Blood, 97, 1219-1226.
2. Atkinson, K. (1990) Chronic graft-versus-host disease. Bone Marrow Transplantation, 5, 69-82.
3. Chiodi, S., Spinelli, S., Ravera, G., Petti, A.R., Van Lint, M.T., Lamparelli, T., Gualandi, F., Occhini, D., Mordini, N., Berisso, G., Bregante, S., Frassoni, F. & Bacigalupo, A. (2000) Quality of life in 244 recipients of allogeneic bone marrow transplantation, British Journal of Haematology, 110, 614-619.
4. Cutler, C., Girl S., Jeyapalan, S., Paniagua, D., Viswanathan, A. & Antin, J.H. (2001) Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. Journal of Clinical Oncology, 19, 3685-3691.
5. Flowers, M.E., Parker, P.M., Johnston, L.J., Matos, A.V., Storer, B., Bensinger, W.I., Storb, R., Appelbaum, F.R., Forman, S.J., Blume, K.G. & Martin, P.J. (2002) Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood, 100, 415-419.
6. Kiss, T.L., Abdolell, M., Jamal, N., Minden, M.D., Lipton, J.H. & Messner, H.A. (2002) Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukaemia followed at least 10 years after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 20, 2334-2343.
7. Koc, S., Leisenring, W., Flowers, M.E., Anasetti, C., Deeg, H.J., Nash, R.A., Sanders, J.E., Witherspoon, R.P., Storb, R., Appelbaum, F.R. & Martin, P.J. (2002) Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood, 100, 48-51.
8. Kodera, Y., Morishima, Y., Kato, S., Akiyama, Y., Sao, H., Matsuyama, T., Kawa, K., Sakamaki, H., Nakagawa, S., Hirabayashi, N., Dohi, H., Okamoto, S., Hiraoka, A., Gondo, H., Tsuchida, M.O.H., Harada, M., Asano, S., Juji, T., Sasazuki, T. & Takaku, F. (1999) Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukaemia and aplastic anemia. Bone Marrow Transplantation, 24, 995-1003.
9. Kulkarni, S., Powles, R., Treleaven, J., Riley, U., Singhal, S., Horton, C., Sirohi, B., Bhagwati, N., Meller, S., Saso, R. & Mehta, J. (2000) Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood, 95, 3683-3686.
10. Lee, J.H., Lee, K.H., Kim, S., Lee, J.S., Kim, W.K., Park, C.J., Chi, H.S. & Kim, S.H. (1998) Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study. Bone Marrow Transplantation, 22, 883-888.
11. Lee, J.H., Lee, K.H., Choi, S.J., Min, Y.J., Khn, J.G., Kim, S., Lee, J.S., Kim, S.H., Park, C.J., Chi, H.S. & Kim, W.K. (2000) Venoocclusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplantation, 26, 657-662.
12. Lee, J.H., Lee, J.H., Lee, J.S., Kim, W.K., Chi, H.S. & Lee, K.H. (2001) Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage of severe aplastic anemia transplanted with marrow from alternative donors other than HLA-identical siblings. Haematologica, 86, 434-435.
13. Lee, K.H., Lee, J.H., Choi, S.J., Kim, S., Lee, J.S., Kim, S.H. & Kim, W.K. (1999) Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 24, 591-599.
14. Lee, K.H., Lee, J.H., Lee, J.H., Kim, W.K., Chi, H.S. & Lee, J./S. (2001) Non-myeloablative conditioning regimen of fludarabine, busulfan, anti-thymocyte globulin, and methylprednisolone for allogeneic peripheral blood hematopoietic cell transplantation. Haematologica, 86, 999-1001.
15. Lee, S.J., Klein, J.P., Barrett, A.J., Ringden, O., Antin, J.H., Cahn, J.Y., Carabasi, M.H., Gale, R.P., Giralt, S., Hale, G.A., Ilhan, O., McCarthy, P.L., Socie, G., Verdonck, L.F., Weisdorf, D.J. & Horowitz, M.M. (2002) Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood, 100, 406-414.
16. Morishima, Y., Morishita, Y., Tanimoto, M., Ohno, R., Saito, H., Horibe, K., Hamajima, N., Naito, K., Yamada, K. & Yokomaku, S. (1989) Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine m Japanese leukaemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. Blood, 74, 2252-2256.
17. Niederwieser, D., Pepe, M., Storb, R., Witherspoon, R., Longton, G. & Sullivan, K. (1989) Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia. Bone Marrow Transplantation, 4, 151-156.
18. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. & Thomas, E.D. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplantation, 15, 825-828.
19. Przepiorka, D., Anderlini, P., Saliba, R., Cleary, K., Mehra, R., Khouri, I., Huh, Y.O., Giralt, S., Braunschweig, I., van Besien, K. & Champlin, R. (2001) Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood, 98, 1695-1700.
20. Ratanatharathorn, V., Ayash, L., Lazarus, H.M., Fu, J. & Uberti, J.P. (2001) Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplantation, 28, 121-129.
21. Ringden, O., Labopin, M., Gluckman, E., Reiffers, J., Vernant, J.P., Jouet, J.P., Harousseau, J.L., Fiere, D., Bacigalupo, A., Frassoni, F. & Gorin, N.C. (1997) Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukaemia treated with methotrexate and cyclosporine. The Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Transplant Proceedings, 29, 733-734.
22. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.S., Storb, R. & Thomas, E.D. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine, 69, 204-217.
23. Socie, G., Stone, J.V., Wingard, J.R., Weisdorf, D., Henslee-Downey, P.J., Bredeson, C., Cahn, J.Y., Passweg, J.R., Rowlings, P.A., Schouten, H.C., Kolb, H.J. & Klein, J.P. (1999) Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. New England Journal of Medicine, 341, 14-21.
24. Storb, R., Prentice, R.L., Sullivan, K.M., Shulman, H.M., Deeg, H.J., Doney, K.C., Buckner, C.D., Clift, R.A., Witherspoon, R.P., Appelbaum, F.A., Sanders, J.E., Stewart, P.S. & Thomas, E.D. (1983) Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Annals of Internal Medicine, 98, 461-466.
25. Sullivan, K.M., Shulman, H.M., Storb, R., Weiden, P.L., Witherspoon, R.P., McDonald, G.B., Schubert, M.M., Atkinson, K. & Thomas, E.D. (1981) Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood, 57, 267-276.
26. Sullivan, K.M., Witherspoon, R.P., Storb, R., Weiden, P., Flournoy, N., Dahlberg, S., Deeg, H.J., Sanders, J.E., Doney, K.C., Appelbaum, F.R., McGuffin, R., McDonald, G.B., Meyers, J., Schubert, M.M., Gauvreau, J., Shulman, H.M., Sale, G.E., Anasetti, C., Loughran, T.P., Strom, S., Nims, J. & Thomas, E.D. (1988a) Predilisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood, 72, 546-554.
27. Sullivan, K.M., Witherspoon, R.P., Storb, R., Deeg, H.J., Dahlberg, S., Sanders, J.E., Appelbaum, F.R., Doney, K.C., Weiden, P., Anasetti, C., Loughran, T.P., Hill, R., Shields, A., Yee, G., Shulman, H., Nims, J., Strom, S. & Thomas, E.D. (1988b) Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood, 72, 555-761.
28. Sullivan, K.M., Agura, E., Anasetti, C., Appelbaum, F., Badger, C., Bearman, S., Erickson, K., Flowers, M., Hansen, J., Loughran, T., Martin, P., Matthews, D., Petersdorf, E., Radich, J., Riddell, S., Rovira, D., Sanders, J., Schuening, F., Siadak, M., Storb, R. & Witherspoon, R.P. (1991) Chronic graft versus host disease in other late complications of bone marrow transplantation. Seminars in Hematology, 28, 250-259.
29. Sullivan, K.M., Storek, J., Kopecky, K.J., Jocom, J., Longton, G., Flowers, M., Siadak, M., Nims, J., Witherspoon, R.P., Anasetti, C., Appelbaum, F.R., Bowden, R.A., Buckner, C.D., Crawford, S.W., Deeg, H.J., Hansen, J.A., McDonald, G.B., Sanders, J.E. & Storb, R. (1996) A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. Biological Blood Marrow Transplantation, 2, 44-53.
30. Sutherland, H.J., Fyles, G.M., Adams, G., Hao, Y., Lipton, J.H., Minden, M.D., Meharchand, J.M., Atkins, H., Tejpar, I. & Messner, H.A. (1997) Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplantation, 19, 1129-1136.
31. Tutschka, P.J., Beschorner, W.E., Hess, A.D. & Santos, G.W. (1983) Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants. Blood, 61, 318-325.
32. Vogelsang, G.B. (2001) How I treat graft-versus-host disease. Blood, 97, 1196-1201.
33. Wagner, F.L., Seidel, K., Boeckh, M, & Storb, R. (2000) De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: risk factors and survival. Biological Blood Marrow Transplantation, 6, 633-639.
34. Weiden, P.L., Sullivan, K.M., Flournoy, N., Storb, R. & Thomas, E.D. (1981) Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. New England Journal of Medicine, 304, 1529-1533.
35. Wingard, J.R., Piantadosi, S., Vogelsang, G.B., Farmer, E.R., Jabs, D.A., Levin, L.S., Beschorner, W.E., Cahill, R.A., Miller, D.F., Harrison, D., Saral, R. & Santos, G.W. (1989) Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood, 74, 1428-1435.
36. Witherspoon, R.P., Storb, R., Ochs, H.D., Fluornoy, N., Kopecky, K.J., Sullivan, K.M., Deeg, J.H., Sosa, R., Noel, D.R., Atkinson, K. & Thomas, E.D. (1981) Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood, 58, 360-368.